Zealand Pharma Announces Positive Phase 2 Results For Petrelintide

Reuters
2026.03.05 18:45
March 5 (Reuters) - Zealand Pharma A/S (ZELA.CO) : * ZEALAND PHARMA ANNOUNCES POSITIVE PHASE 2 RESULTS FOR PETRELINTIDE, AN AMYLIN ANALOG WITH POTENTIAL TO REDEFINE THE WEIGHT MANAGEMENT EXPERIENCE FOR PEOPLE LIVING WITH OVERWEIGHT AND OBESITY * ZEALAND PHARMA - PHASE 2 TRIAL MEETS PRIMARY ENDPOINT WITH SIGNIFICANT WEIGHT REDUCTION AT 28 WEEKS * ZEALAND PHARMA: NO UNEXPECTED SAFETY SIGNALS WERE OBSERVED WITH PETRELINTIDE TREATMENT Source text: Further company coverage: (ZELA.CO)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer